{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "British drug maker AstraZeneca agrees to buy ZS Pharma for $2.7 billion.", "type_of_material": "News", "word_count": "348", "lead_paragraph": "The transaction is expected to improve the British drug maker\u2019s pipeline of treatments for cardiovascular and metabolic diseases.", "pub_date": "2015-11-07T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "AstraZeneca Agrees to Buy ZS Pharma for $2.7 Billion", "print_headline": "Business Briefing; AstraZeneca Agrees to Buy ZS Pharma for $2.7 Billion"}, "snippet": "The transaction is expected to improve the British drug maker\u2019s pipeline of treatments for cardiovascular and metabolic diseases.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/11/07/business/dealbook/astrazeneca-agrees-to-buy-zs-pharma-for-2-7-billion.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "AstraZeneca PLC", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "ZS Pharma Inc.", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Great Britain", "name": "glocations"}, {"rank": "7", "is_major": "N", "value": "California", "name": "glocations"}, {"rank": "8", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}], "blog": [], "_id": "563c704038f0d86bed6b712d", "source": "The New York Times"}